Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry.
The company plans to display the pen at Pharmapack Europe, according to a news release.
“A pen injector is an important addition to Phillips-Medisize’s expanding product and platform portfolio that empowers biopharma companies to accelerate the rollout of novel and generic drug treatments at significant economies of scale,” said Paul Chaffin, SVP and president of medical and pharmaceutical solutions, Molex. “This ‘ready to go’ solution offers all of the advantages expected from ‘state of the art’ pen designs while benefiting from our decades of device development and large-volume manufacturing expertise to reduce the challenges of bringing affordable drugs and drug-delivery devices to market.”
Get the full story at our sister site, Drug Delivery Business News.